In the present study, we attempted to evaluate the efficacy of the combination therapy using VEGF-Trap and gemcitabine in a mouse LLC lung cancer model, and to investigate the possible mechanism responsible for the increased anti-tumor efficacy. The gene discussed is VEGFA; the disease is lung carcinoma.